Petkovska Iva, Shah Sumit K, McNitt-Gray Michael F, Goldin Jonathan G, Brown Matthew S, Kim Hyun J, Brown Kathleen, Aberle Denise R
Department of Radiological Sciences, David Geffen School of Medicine at University of California Los Angeles, Thoracic Imaging Research Group, Los Angeles, CA 90095-7319, USA.
Eur J Radiol. 2006 Aug;59(2):244-52. doi: 10.1016/j.ejrad.2006.03.005. Epub 2006 Apr 17.
To determine whether conventional nodule densitometry or analysis based on contrast enhancement maps of indeterminate lung nodules imaged with contrast-enhanced CT can distinguish benign from malignant lung nodules.
Thin section, contrast-enhanced CT (baseline, and post-contrast series acquired at 45, 90,180, and 360 s) was performed on 29 patients with indeterminate lung nodules (14 benign, 15 malignant). A thoracic radiologist identified the boundary of each nodule using semi-automated contouring to form a 3D region-of-interest (ROI) on each image series. The post-contrast series having the maximum mean enhancement was then volumetrically registered to the baseline series. The two series were subtracted volumetrically and the subtracted voxels were quantized into seven color-coded bins, forming a contrast enhancement map (CEM). Conventional nodule densitometry was performed to obtain the maximum difference in mean enhancement values for each nodule from a circular ROI. Three thoracic radiologists performed visual semi-quantitative analysis of each nodule, scoring each map for: (a) magnitude and (b) heterogeneity of enhancement throughout the entire volume of the nodule on a five-point scale. Receiver operator characteristic (ROC) analysis was conducted on these features to evaluate their diagnostic efficacy. Finally, 14 quantitative texture features were calculated for each map. A statistical analysis was performed to combine the 14 texture features to a single factor. ROC analysis of the derived aggregate factor was done as an indicator of malignancy. All features were analyzed for differences between benign and malignant nodules.
Using 15 HU as a threshold, 93% (14/15) of malignant and 79% (11/14) of benign nodules demonstrated enhancement. The ROC curve when higher values of enhancement indicate malignancy was generated and area under the curve (AUC) was 0.76. The visually scored magnitude of enhancement was found to be less effective in distinguishing malignant from benign lesions, with an average AUC of 0.62. The visually scored pattern of enhancement was found to be more effective with an average AUC of 0.79. From the statistical analysis performed to combine the texture features to a single factor, the area under the ROC curve was 0.84.
The present study suggests that visual semi-quantitative and quantitative characterization of contrast enhancement patterns may potentially enhance the discrimination between benign and malignant nodules. Further studies and correlation with pathologic material will be important to better understand the potential interplay between CT enhancement features, host stromal elements, and neovascularity that may contribute to these patterns.
确定传统的结节密度测定法或基于增强CT成像的不确定肺结节对比增强图分析能否区分肺良性结节与恶性结节。
对29例患有不确定肺结节的患者(14例良性,15例恶性)进行薄层增强CT检查(包括基线扫描以及在45、90、180和360秒时采集的增强后系列扫描)。一位胸部放射科医生使用半自动轮廓描绘法确定每个结节的边界,以便在每个图像系列上形成一个三维感兴趣区(ROI)。然后将具有最大平均增强值的增强后系列扫描与基线系列扫描进行体积配准。将这两个系列扫描进行体积相减,并将相减后的体素量化为七个颜色编码的区间,从而形成一个对比增强图(CEM)。进行传统的结节密度测定,以从圆形ROI获得每个结节平均增强值的最大差异。三位胸部放射科医生对每个结节进行视觉半定量分析,以五点量表对每个图的以下方面进行评分:(a)增强幅度和(b)整个结节体积内增强的异质性。对这些特征进行受试者操作特征(ROC)分析,以评估其诊断效能。最后,为每个图计算14个定量纹理特征。进行统计分析,将14个纹理特征合并为一个单一因素。对得出的综合因素进行ROC分析,作为恶性肿瘤的指标。分析所有特征在良性和恶性结节之间的差异。
以15HU作为阈值,93%(14/15)的恶性结节和79%(11/14)的良性结节显示有增强。生成了增强值越高表明为恶性的ROC曲线,曲线下面积(AUC)为0.76。发现视觉评分的增强幅度在区分恶性和良性病变方面效果较差,平均AUC为0.62。发现视觉评分的增强模式效果更好,平均AUC为0.79。从将纹理特征合并为一个单一因素的统计分析中,ROC曲线下面积为0.84。
本研究表明,对比增强模式的视觉半定量和定量特征可能会增强对良性和恶性结节的鉴别能力。进一步的研究以及与病理材料的相关性对于更好地理解CT增强特征、宿主基质成分和新生血管之间可能导致这些模式的潜在相互作用至关重要。